Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-26 @ 1:52 PM
Study NCT ID:
NCT01650259
Status:
COMPLETED
Last Update Posted:
2019-09-18
First Post:
2012-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-24
First Submit QC Date:
None
Study First Post Date:
2012-07-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-20
Results First Submit QC Date:
None
Results First Post Date:
2019-05-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-03
Last Update Post Date:
2019-09-18
Last Update Post Date Type:
ACTUAL